Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.890
-0.100 (-5.03%)
Mar 31, 2025, 1:43 PM EDT - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $241.28 million as of March 31, 2025. Its market cap has decreased by -73.59% in one year.
Market Cap
241.28M
Enterprise Value
104.40M
1-Year Change
-73.59%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $241.28M, a decrease of -85.17%. That is a compound annual growth rate of -54.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 254.05M | -31.81% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |